3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
28
Melanoma
25
Carcinoma, Renal Cell
22
Lung Neoplasms
11
Neoplasm Metastasis
10
Squamous Cell Carcinoma of Head and Neck
9
Neoplasms
9
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Hodgkin Disease
8
Carcinoma, Transitional Cell
7
Carcinoma, Hepatocellular
7
Adenocarcinoma Of Esophagus
7
Triple Negative Breast Neoplasms
6
Stomach Neoplasms
6
Rectal Neoplasms
6
Ovarian Neoplasms
6
Pancreatic Neoplasms
5
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Nasopharyngeal Carcinoma
4
Multiple Myeloma
4
Endometrial Neoplasms
4
Carcinoma, Merkel Cell
4
Carcinoma, Basal Cell
4
Brain Neoplasms
4
Anus Neoplasms
4
Thyroid Neoplasms
3
Sarcoma, Kaposi
3
Recurrence
3
Interventions
venetoclax
6
ibrutinib
4
pirtobrutinib
2
Sirolimus
2
Rituximab
2
Mycophenolic Acid
2
Cyclosporine
2
Cyclophosphamide
2
zanubrutinib
1
pembrolizumab
1
loncastuximab tesirine
1
fludarabine phosphate
1
carfilzomib
1
acalabrutinib
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Rifaximin
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Etoposide
1
Dexamethasone
1
Cyclosporins
1
Calcium Dobesilate
1
CT-P10
1
Busulfan
1
Biopsy
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Nivolumab
×
30 days
×
Clear all
No trials found.